C5aR program (ChemoCentryx)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameC5aR program (ChemoCentryx)
Drug Alias NameC5aR program (ChemoCentryx/GlaxoSmithKline)CCX-1378CCX-1641
ClassificationSmall molecules
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsVasculitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemocentryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcChemocentryx Inc
Active IndicationsN/A
Inactive IndicationsVasculitis

Other Information

ATC CodeN/A
Related LinksN/A